Home

new and NoteWorthy
  • GLP-1s: Medicaid Coverage of and Spending

    A new KFF analysis examines the implications of rising prescriptions for costly GLP-1 drugs for state Medicaid programs as more states consider covering the drugs for weight loss.

  • Ten Things to Watch for 2025 ACA Open Enrollment

    On the heels of three straight years of record high enrollment, the 12th annual Affordable Care Act (ACA) Marketplace open enrollment season will be another opportunity for more people to gain coverage. Here are ten things to know about the 2025 open enrollment period.

  • The Impact of Inflation Reduction Act Insurance Subsidies

    Enhanced premium subsidies were first made available under the American Rescue Plan Act and extended until the end of 2025 under the Inflation Reduction Act. This analysis shows the impact that enhanced subsidies have had on enrollment and premium payments, and the potential implications if the enhanced subsidies expire.

  • Beyond the Data, a Column by Drew Altman

    In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people. 

Browse the Latest from KFF

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.